查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1629875

全球诊断影像设备市场 - 2025-2033

Global Diagnostic Imaging Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球诊断影像设备市场规模达337亿美元，预计2033年将达到526亿美元，2025-2033年预测期间复合年增长率为5.1%。

诊断影像设备是一种医疗技术，用于创建身体内部的视觉表示，以进行临床分析和医疗干预。这些设备透过提供器官、组织、骨骼和血管的详细影像，在诊断、监测和治疗各种医疗状况方面发挥关键作用。它们是现代医学的重要工具，因为它们可以帮助医疗保健提供者识别疾病、确定损伤程度、监测疾病进展以及计划手术或治疗。

在医疗保健需求增加、技术进步和慢性病盛行率不断上升等多种因素的推动下，全球诊断影像市场需求强劲。例如，根据美国疾病管制与预防中心的数据，估计有 1.29 亿美国人患有至少一种美国卫生部定义的主要慢性疾病（例如心臟病、癌症、糖尿病、肥胖、高血压）和人类服务。在美国十大死亡原因中，有五个与可预防和可治疗的慢性疾病密切相关。

市场动态：

驱动程式和限制

诊断影像设备不断进步的技术

诊断影像设备不断进步的技术进步极大地推动了诊断影像设备市场的成长，预计将在预测期内透过提高诊断准确性、效率和患者治疗结果来推动市场发展。这些创新不仅增强了影像系统的功能，也扩展了其在各个临床学科的应用。

人工智慧和机器学习透过提高影像分析的速度和准确性正在彻底改变诊断成像。人工智慧工具可以快速识别影像中的模式，协助检测异常情况并为医疗保健专业人员提供决策支援。例如，2024 年 12 月，皇家飞利浦宣布在该公司最近推出的 CT 5300 系统中提供人工智慧和智慧工作流程自动化功能的临床决策支援。飞利浦CT 智慧工作流程具有一整套支援AI 的「精确」软体解决方案，可协助CT 工作流程的每一步，将技术人员和放射科医生从日常耗时的任务中解放出来，让他们有更多时间专注于患者。

3D MRI 和 3D 超音波等技术改变了医疗保健专业人员可视化和诊断病情的方式。这些进步对于更好的手术规划和疾病进展监测至关重要。例如，2024 年 5 月，Koelis, SAS 在着名的美国泌尿外科协会年会上发布了新功能，展示其将人工智慧增强的前列腺 MRI 功能整合到其独家 Trinity 平台中的新颖能力。 Koelis Trinity 系统使泌尿科医生能够对前列腺癌进行 3D 靶向「融合活检」。 Trinity 将 3D 超音波成像与专有的 MRI-US 融合影像引导相集成，该影像引导采用该公司独特的前列腺运动追踪软体 (OBT Fusion)。

可携式诊断影像设备，例如手持式超音波机，正在改善获得护理的机会，特别是在农村或服务不足的地区。这些设备具有移动性、成本效益以及在护理点进行诊断的能力，从而减少了患者长途跋涉前往医疗机构的需要。

例如，2023 年 2 月，Carestream Health India 推出了高效能 Carestream Motion 行动 X 光系统。本系统设备齐全，可进行全方位的一般放射线检查。新型便携式成像系统结构紧凑，易于在狭小的空间内操作。管头和铰接臂等创新功能可实现出色的可视性且易于使用。

诊断影像设备成本高

诊断影像设备的高成本预计将阻碍市场成长，特别是在新兴经济体和小型医疗机构。 MRI、CT 扫描仪和 PET 扫描仪等诊断影像设备需要大量的前期投资，成本可能很高。这是一个重大障碍，特别是对于规模较小的医疗中心或财政资源有限的发展中地区的医疗中心而言。

例如，根据 Block Imaging, Inc. 的说法，CT 扫描器的平均成本根据型号和功能的不同而有很大差异，价格从基本型号的 80,000 美元到高级型号的高达 300,000 美元不等。通常，买家预计花费 12 万至 16 万美元购买一台中级 CT 扫描仪。 PET/CT 扫描仪的平均成本从入门级扫描仪的 225,000 美元到优化扫描系统的 475,000 美元不等。最新最好的 PET/CT 扫描仪价格高达 750,000 美元。

除了高昂的前期成本之外，这些成像设备还具有相当大的持续维护和营运费用。需要定期维护、软体升级和维修，以保持设备高效运作。这增加了总体负担，特别是在发展中经济体，那里的医院和诊断中心可能已经在预算紧张的情况下挣扎。

目录

第一章：市场介绍和范围

  • 报告的目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分類的片段
  • 按成像类型分類的片段
  • 可移植性片段
  • 按应用程式片段
  • 最终使用者的片段
  • 按地区分類的片段

第 3 章：动力学

  • 影响因素
    • 司机
      • 诊断影像设备不断进步的技术
      • 慢性病盛行率上升和人口老化
    • 限制
      • 诊断影像设备成本高昂
    • 机会
    • 影响分析

第 4 章：策略洞察与产业展望

  • 市场领导者和先驱
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的知名领导者
    • 拥有成熟产品的市场领导者
  • 新兴新创企业和关键创新者
  • CXO 观点
  • 最新进展和突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：诊断影像设备市场（依产品类型）

  • PET/CT 扫描仪
  • C型臂
  • 核磁共振机
  • 乳房X光摄影系统
  • 骨密度计
  • 其他的

第 6 章：诊断影像设备市场（依影像类型）

  • X射线影像
  • 电脑断层扫描 (CT)
  • 磁振造影 (MRI)
  • 超音波
  • 核子造影
  • 乳房X光检查
  • 其他的

第 7 章：诊断影像设备市场（按便携性）

  • 便携式设备
  • 手持装置
  • 固定设备

第 8 章：诊断影像设备市场（按应用）

  • 心臟病学
  • 肿瘤学
  • 神经病学
  • 骨科
  • 泌尿科
  • 胃肠病学
  • 其他的

第 9 章：诊断影像设备市场（按最终用户）

  • 医院
  • 诊断中心
  • 专科诊所
  • 其他的

第 10 章：诊断影像设备市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的主要发展
  • 公司基准化分析

第 12 章：公司简介

  • Siemens Healthineers AG
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT分析
  • GE HealthCare
  • Koninklijke Philips NV
  • CANON MEDICAL SYSTEMS CORPORATION
  • FUJIFILM Holdings Corporation
  • Medtronic plc
  • Hologic, Inc.
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Carestream Health

第 13 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 14 章：附录

简介目录
Product Code: MD8905

The global diagnostic imaging devices market reached US$ 33.7 billion in 2024 and is expected to reach US$ 52.6 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

Diagnostic imaging devices are medical technologies used to create visual representations of the interior of a body for clinical analysis and medical intervention. These devices play a critical role in diagnosing, monitoring, and treating various medical conditions by providing detailed images of organs, tissues, bones, and blood vessels. They are crucial tools in modern medicine, as they help healthcare providers identify diseases, determine the extent of an injury, monitor disease progression, and plan surgeries or treatments.

The global diagnostic imaging market is experiencing robust demand, driven by various factors such as increasing healthcare needs, technological advancements and the growing prevalence of chronic diseases. For instance, according to the Centers for Disease Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Five of the top 10 leading causes of death in the US are or are strongly associated with preventable and treatable chronic diseases.

Market Dynamics: Drivers & Restraints

Rising technological advancements in diagnostic imaging devices

Rising technological advancements in diagnostic imaging devices are significantly driving the growth of the diagnostic imaging devices market and are expected to drive the market over the forecast period by improving diagnostic accuracy, efficiency and patient outcomes. These innovations not only enhance the capabilities of imaging systems but also expand their applications across various clinical disciplines.

AI and machine learning are revolutionizing diagnostic imaging by improving the speed and accuracy of image analysis. AI tools can quickly identify patterns in images, assist in detecting abnormalities and provide decision support to healthcare professionals. For instance, in December 2024, Royal Philips announced clinical decision-support with AI and smart workflow automation capabilities in the company's recently introduced CT 5300 system. Philips' CT Smart Workflow features a comprehensive suite of AI-enabled 'Precise' software solutions that assist at every step of the CT workflow, freeing technicians and radiologists from routine, time-consuming tasks and allowing them more time to focus on their patients.

Technologies like 3D MRI and 3D ultrasound have transformed how healthcare professionals visualize and diagnose conditions. These advancements are crucial for better surgical planning and monitoring of disease progression. For instance, in May 2024, Koelis, SAS released new features at the prestigious American Urological Association Annual Meeting to demonstrate its novel capacity to integrate AI-enhanced prostate MRI features into its exclusive Trinity platform. The Koelis Trinity system enables urologists to perform 3D targeted "fusion biopsy" in prostate cancer. Trinity integrates 3D ultrasound imaging with proprietary MRI-US fusion image guidance that features the Company's unique prostate motion tracking software (OBT Fusion).

Portable diagnostic imaging devices, such as handheld ultrasound machines, are improving access to care, especially in rural or underserved areas. These devices offer mobility, cost-effectiveness, and the ability to perform diagnostics at the point of care, reducing the need for patients to travel long distances to healthcare facilities.

For instance, in February 2023, Carestream Health India launched its high-powered Carestream Motion Mobile X-ray system. The system is fully equipped to carry out a full range of general radiography examinations. The new portable imaging system is compact and easy to maneuver into tight spaces. Innovative features such as a tube head and articulating arm for excellent visibility and easy use.

High cost of diagnostic imaging devices

The high cost of diagnostic imaging devices is expected to hamper the market growth, especially in emerging economies and small healthcare facilities. Diagnostic imaging devices such as MRI, CT scanners, and PET scanners require substantial upfront investments, which can be cost highly. This is a significant barrier, particularly for smaller healthcare centers or those in developing regions with limited financial resources.

For instance, according to Block Imaging, Inc., the average cost for a CT scanner varies significantly depending on the model and features, with prices ranging from $80,000 for basic models to up to $300,000 for premium. Typically, buyers can expect to spend between $120,000 and $160,000 for an intermediate-level CT scanner. The average cost of a PET/CT scanner can range from $225,000 for an entry-level scanner to $475,000 for an optimized scanning system. PET/CT scanners can go as high as $750,000 for the latest and greatest.

In addition to high upfront costs, these imaging devices have considerable ongoing maintenance and operational expenses. Regular servicing, software upgrades and repairs are required to keep the equipment functioning efficiently. This adds to the overall burden, especially in developing economies where hospitals and diagnostic centers may already be struggling with tight budgets.

Segment Analysis

The global diagnostic imaging devices market is segmented based on product type, imaging type, portability, application, end-user and region.

Product Type:

The PET/CT scanners segment is expected to dominate the diagnostic imaging devices market share

The PET/CT scanners segment is expected to dominate the global diagnostic imaging devices market. PET/CT scanners combine Positron Emission Tomography (PET) and Computed Tomography (CT), allowing physicians to obtain both functional and anatomical images in a single scan. This fusion of technologies enables on-site technological upgrades, more accurate detection, staging and monitoring of diseases.

For instance, in July 2024, Positron announced that the company is launching its NeuSight PET/CT 3D 64-slice scanner in the U.S. and North American markets. Suitable for both cardiology and oncology imaging, the NeuSight PET/CT scanner offers anatomic and functional imaging for heart, tumor and brain imaging studies.

Continuous advancements in PET/CT scanner technology are making these devices more efficient and accessible. Innovations such as higher-resolution imaging, faster scan times, and improved patient comfort are boosting the adoption of these devices. For instance, in June 2024, Siemens Healthineers unveiled its latest PET/CT scanner, cleared by the U.S. Food and Drug Administration and features a scalable axial field-of-view design that enables on-site technological upgrades without costly room renovations or impeding workflow.

Geographical Analysis

North America is expected to hold a significant position in the diagnostic imaging devices market share

North America is expected to hold the largest market share in the global diagnostic imaging devices market. North America especially the United States is often the first region to adopt new diagnostic imaging technologies, including advanced MRI systems, digital X-rays and AI-powered imaging devices along with the strong presence of major players. The early adoption of innovations allows North America countries to maintain their leadership in the global market.

For instance, in October 2024, FUJIFILM Healthcare Americas Corporation launched the Version 10 (v10) suite of innovations for the ECHELON Synergy 1.5T MRI system. ECHELON Synergy v10 deploys several cutting-edge technologies, including Synergy DLR Clear, Synergy Vision with StillShot and automated scanning process enhancements.

North America, particularly the United States hosts some of the world's largest diagnostic imaging device manufacturers, such as GE Healthcare, Philips Healthcare, Siemens Healthineers and Canon Medical Systems. These companies invest heavily in research and development (R&D) to create next-generation imaging systems that continue to push the boundaries of diagnostic capabilities.

For instance, in December 2024, GE HealthCare unveiled Sonic DL for 3D, a new deep-learning innovation for the company's imaging portfolio. GE HealthCare initially launched Sonic DL in 2023. The company says it provides up to 12 times scan acceleration while maintaining diagnostic quality. This latest enhancement brings the system to 3D volumetric imaging. GE HealthCare wants to broaden the platform's applicability to brain, spine, orthopedic and body exams in addition to cardiac.

Asia-Pacific is growing at the fastest pace in the diagnostic imaging devices market

The Asia-Pacific region is experiencing the fastest growth in the diagnostic imaging devices market. The region is rapidly adopting advanced diagnostic imaging technologies, including AI-powered imaging devices, portable ultrasound machines and hybrid systems (e.g., PET/CT). These innovations are making diagnostic imaging more efficient, affordable and accessible in the region.

For instance, in October 2023, Abbott launched its new vascular imaging platform powered by Ultreon 1.0 Software in India. This first-of-its-kind intra-vascular imaging software combines optical coherence tomography (OCT) with the power of artificial intelligence (AI) providing physicians a comprehensive view of blood flow and blockages within coronary arteries. The innovative imaging software can automatically differentiate between a calcified and non-calcified blockage, detect the severity of calcium-based blockages and measure vessel diameter.

Additionally, in July 2024, Trivitron Healthcare launched its Terrene CT scanner in India. The scanner has received approvals from the Bureau of Indian Standards, Atomic Energy Regulatory Board, and Central Drugs Standard Control Organization, marking a significant milestone in the Indian healthcare industry.

Competitive Landscape

The major global players in the diagnostic imaging devices market include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Medtronic plc, Hologic, Inc., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Carestream Health and among others.

Key Developments

  • In August 2024, Fischer Medical Ventures (FMVL) introduced indigenously developed Computed Tomography (CT) scans. The company developed India's first indigenous Magnetic Resonance Imaging (MRI) system. The company, celebrating its listing on the Bombay Stock Exchange (BSE), announced plans to introduce domestically produced CT scans in collaboration with Edusoft at half the price of current market offerings.
  • In July 2024, LG Electronics (LG) announced that the company expanding its lineup of diagnostic monitors with the new 21HQ613D-B, which was recently cleared by the U.S. Food and Drug Administration for sale in the U.S. Intended for digital mammography and digital breast tomosynthesis, the 21HQ613D-B is a 21.3-inch 5-megapixel (MP) IPS diagnostic monitor designed to deliver high-definition radiological images and maintains consistent image quality through its internal front calibration sensor and calibration software.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews clinical trials, product pipelines, and future advancements in medical devices.
  • Product Performance & Market Positioning: Analyzes product performance and market positioning to refine strategies.
  • Real-World Evidence: Uses patient feedback and data to improve device outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and health system mergers' impact on adoption.
  • Market Updates & Industry Changes: Covers regulatory changes, new policies, and emerging technologies in medical devices.
  • Competitive Strategies: Analyzes competitor strategies, market share, and new entrants in the market.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and access strategies.
  • Market Entry & Expansion: Identifies strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights regions with growth opportunities and investment potential.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and regulatory changes.
  • Post-market Surveillance: Uses post-market data to enhance device safety and access.
  • Cost-Effectiveness & Value-Based Healthcare: Analyzes cost-effectiveness and value-based models in device pricing and adoption.

The global diagnostic imaging devices market report delivers a detailed analysis with 78 key tables, more than 84 visually impactful figures, and 183 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Imaging Type
  • 2.5. Snippet by Portability
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in Diagnostic Imaging Devices
      • 3.1.1.2. Rising Prevalence of Chronic Diseases and Aging Population
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Diagnostic Imaging Devices
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Diagnostic Imaging Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. PET/CT Scanners*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. C-Arms
  • 5.4. MRI Machines
  • 5.5. Mammography Systems
  • 5.6. Bone Densitometers
  • 5.7. Others

6. Diagnostic Imaging Devices Market, By Imaging Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 6.1.2. Market Attractiveness Index, By Imaging Type
  • 6.2. X-Ray Imaging*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Computed Tomography (CT)
  • 6.4. Magnetic Resonance Imaging (MRI)
  • 6.5. Ultrasound
  • 6.6. Nuclear Imaging
  • 6.7. Mammography
  • 6.8. Others

7. Diagnostic Imaging Devices Market, By Portability

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 7.1.2. Market Attractiveness Index, By Portability
  • 7.2. Portable Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Handheld Devices
  • 7.4. Stationary Equipments

8. Diagnostic Imaging Devices Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Oncology
  • 8.4. Neurology
  • 8.5. Orthopedics
  • 8.6. Urology
  • 8.7. Gastroenterology
  • 8.8. Others

9. Diagnostic Imaging Devices Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. Diagnostic Imaging Devices Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Siemens Healthineers AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. GE HealthCare
  • 12.3. Koninklijke Philips N.V.
  • 12.4. CANON MEDICAL SYSTEMS CORPORATION
  • 12.5. FUJIFILM Holdings Corporation
  • 12.6. Medtronic plc
  • 12.7. Hologic, Inc.
  • 12.8. Abbott Laboratories
  • 12.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 12.10. Carestream Health

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us